Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01612767 · ClinicalTrials.gov registry record · Phase 2
BIOHELIX-I Bare Metal Stent Study
A Phase 2 study, sponsored by Biotronik.
- Completed
- Registry status
- Phase 2
- Development phase
- 329
- Enrollment target
NCT01612767 is a Phase 2 study that has completed, run by Biotronik. The registered enrollment target is 329 participants.
The verdict
NCT01612767, a Phase 2 study, has completed, sponsored by Biotronik.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 329 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate the safety and efficacy of the investigational BIOTRONIK PRO-Kinetic Energy stent in subjects with atherosclerotic disease of native coronary arteries.
Interventions
- DEVICE PRO-Kinetic Energy Stent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 329 participants |
| Start Date | 2012-11 |
| Est. Completion | 2017-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01612767
The ClinicalTrials.gov registry entry for NCT01612767 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 329 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biotronik, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PRO-Kinetic Energy Stent is the first listed.
NCT01612767 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01612767 about?
NCT01612767 is a clinical study titled "BIOHELIX-I Bare Metal Stent Study". The purpose of this study is to demonstrate the safety and efficacy of the investigational BIOTRONIK PRO-Kinetic Energy stent in subjects with atherosclerotic disease of native coronary arteries.
What is the current status of trial NCT01612767?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 329 participants. The study started on 2012-11. Estimated completion is 2017-11.
What interventions are being tested in trial NCT01612767?
The interventions under investigation include: PRO-Kinetic Energy Stent (DEVICE).
Who is sponsoring clinical trial NCT01612767?
This trial is sponsored by Biotronik, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.